Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.

作者: Hyog Young Kwon , Jeevisha Bajaj , Takahiro Ito , Allen Blevins , Takaaki Konuma

DOI: 10.1016/J.STEM.2015.06.006

关键词:

摘要: SUMMARY Acute Myelogenous Leukemia (AML) is an aggressive cancer that strikes both adults and children frequently resistant to therapy. Thus, identifying signals needed for AML propagation a critical step toward developing new approaches treating this disease. Here, we show Tetraspanin 3 target of the RNA binding protein Musashi 2, which plays key role in AML. We generated Tspan3 knockout mice were born without overt defects. However, deletion impaired leukemia stem cell self-renewal disease markedly improved survival mouse models Additionally, inhibition blocked growth patient samples, suggesting also important human As part mechanism, deficiency disabled responses CXCL12/SDF-1 led defects localization within niche. These identify as regulator leukemias highlight oncogenesis.

参考文章(48)
Piotr Smolewski, Pawel Robak, Tadeusz Robak, TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies. Current opinion in investigational drugs. ,vol. 10, pp. 1383- 1390 ,(2009)
George Paxinos, Keith B. J. Franklin, Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates ,(2012)
Padraic MacMathuna, Alan C. Moss, Peter P. Doran, In Silico Promoter Analysis can Predict Genes of Functional Relevance in Cell Proliferation: Validation in a Colon Cancer Model. Translational oncogenomics. ,vol. 2, pp. 1- 16 ,(2007) , 10.4137/TOG.S0
Martin E. Hemler, Brian A. Mannion, Fedor Barditchevski, Association of TM4SF proteins with integrins: relevance to cancer Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. ,vol. 1287, pp. 67- 71 ,(1996) , 10.1016/0304-419X(96)00007-8
Bryan Zimdahl, Takahiro Ito, Allen Blevins, Jeevisha Bajaj, Takaaki Konuma, Joi Weeks, Claire S Koechlein, Hyog Young Kwon, Omead Arami, David Rizzieri, H Elizabeth Broome, Charles Chuah, Vivian G Oehler, Roman Sasik, Gary Hardiman, Tannishtha Reya, Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia Nature Genetics. ,vol. 46, pp. 245- 252 ,(2014) , 10.1038/NG.2889
Zejuan Li, Zhiyu Zhang, Yuanyuan Li, Stephen Arnovitz, Ping Chen, Hao Huang, Xi Jiang, Gia-Ming Hong, Rejani B. Kunjamma, Haomin Ren, Chunjiang He, Chong-Zhi Wang, Abdel G. Elkahloun, Peter J. M. Valk, Konstanze Döhner, Mary Beth Neilly, Lars Bullinger, Ruud Delwel, Bob Löwenberg, Paul P. Liu, Richard Morgan, Janet D. Rowley, Chun-Su Yuan, Jianjun Chen, PBX3 is an important cofactor of HOXA9 in leukemogenesis Blood. ,vol. 121, pp. 1422- 1431 ,(2013) , 10.1182/BLOOD-2012-07-442004
Chen Zhao, Jordan Blum, Alan Chen, Hyog Young Kwon, Seung Hye Jung, J. Michael Cook, Anand Lagoo, Tannishtha Reya, Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo Cancer Cell. ,vol. 12, pp. 528- 541 ,(2007) , 10.1016/J.CCR.2007.11.003
Anke C. Spoo, Michael Lübbert, William G. Wierda, Jan A. Burger, CXCR4 is a prognostic marker in acute myelogenous leukemia Blood. ,vol. 109, pp. 786- 791 ,(2007) , 10.1182/BLOOD-2006-05-024844
Tadeusz Robak, Application of new drugs in chronic lymphocytic leukemia. Mediterranean Journal of Hematology and Infectious Diseases. ,vol. 2, pp. 2010011- ,(2010) , 10.4084/MJHID.2010.011
J. P. Radich, H. Dai, M. Mao, V. Oehler, J. Schelter, B. Druker, C. Sawyers, N. Shah, W. Stock, C. L. Willman, S. Friend, P. S. Linsley, Gene expression changes associated with progression and response in chronic myeloid leukemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 2794- 2799 ,(2006) , 10.1073/PNAS.0510423103